Affineti Biologics

In 1987, with a deep focus on coagulation and hemostasis, Hugh and Patricia Hoogendoorn founded Affinity Biologicals in Ancaster, Ontario. Their goal was to become a primary manufacturer of the critical reagents and testing kits that scientists and researchers rely on for thrombosis and hemostasis diagnostics. The company established a niche, developing a comprehensive catalog of over 300 products, including specialized antibodies, complete ELISA kits, and various human plasma products. For over three decades, Affinity Biologicals operated as a foundational, yet often unseen, player in the life sciences space. They weren't a company chasing headlines but focused on execution and quality, manufacturing products for a global market through a network of distributors. This dedication to the fundamentals of research and diagnostics built a solid, respected business in its field. The company's journey took a significant turn in November 2018 when it was acquired by Precision BioLogic, a Halifax-based developer of hemostasis diagnostic products. The move was described by both parties as a "logical fit," as the two companies served similar markets with complementary product lines. The acquisition marked the end of an era for Affinity Biologicals as a standalone family-founded company but integrated its specialized manufacturing capabilities into a larger strategic plan to advance hemostasis diagnostics.